Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Eiken Kagaku Kabushiki Kaisha has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 3 distinct examiners and 3 distinct art units. Each pending matter therefore occupies a separate examination setting within the portfolio.
IVICH, FERNANDO NMN is the busiest examiner, with 1 pending matter. The current record does not show examiner concentration. Counsel should maintain separate response strategies for the biotechnology and pharmaceutical matters, while coordinating docket management so that differences in examiner and art-unit treatment are preserved in prosecution decisions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §112 only | 1 (33%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IVICH, FERNANDO NMN | 1 | 52.4% | +72.2% |
| YOUNG, BRIAN ELLIS | 1 | 65.0% | +28.3% |
| KAPUSHOC, STEPHEN THOMAS | 1 | 46.5% | +53.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18687554 | ANTIBODY, IMMOBILIZED ANTIBODY USING THE SAME, ANTIBODY COMPOSITION, REAGENT FOR IMMUNOASSAY AND IMMUNOASSAY METHOD, AS WELL AS METHOD FOR IMPROVING REACTIVITY OF ANTIBODY WITH ANTIGEN | IVICH, FERNANDO NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18687554 | ANTIBODY, IMMOBILIZED ANTIBODY USING THE SAME, ANTIBODY COMPOSITION, REAGENT FOR IMMUNOASSAY AND IMMUNOASSAY METHOD, AS WELL AS METHOD FOR IMPROVING REACTIVITY OF ANTIBODY WITH ANTIGEN | IVICH, FERNANDO NMN | — |
| 17811485 | METHOD FOR DETECTING TARGET NUCLEIC ACID AND NUCLEIC ACID PROBE USED THEREIN | YOUNG, BRIAN ELLIS | — |
| 17833231 | METHOD FOR DESIGNING A PROBE COMBINATION | KAPUSHOC, STEPHEN THOMAS | — |
| Art Unit | Apps |
|---|---|
| 1678 | 1 |
| 1684 | 1 |
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18687554 | ANTIBODY, IMMOBILIZED ANTIBODY USING THE SAME, ANTIBODY COMPOSITION, REAGENT FOR IMMUNOASSAY AND IMMUNOASSAY METHOD, AS WELL AS METHOD FOR IMPROVING REACTIVITY OF ANTIBODY WITH ANTIGEN | IVICH, FERNANDO NMN | 1678 | §101§102§103 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 17811485 | METHOD FOR DETECTING TARGET NUCLEIC ACID AND NUCLEIC ACID PROBE USED THEREIN | YOUNG, BRIAN ELLIS | 1684 | §112Other | Non-Final OA | — | Pending | Jul 08, 2022 |
| 17833231 | METHOD FOR DESIGNING A PROBE COMBINATION | KAPUSHOC, STEPHEN THOMAS | 1683 | Other | Final Rejection | — | Pending | Jun 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEiken Kagaku Kabushiki Kaisha has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Fernando Nmn Ivich has the most, with 1 of Eiken Kagaku Kabushiki Kaisha's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
